Discover Beauty and Confidence

Dive into our diverse treatment options and embark on a journey to discover your best self.

Neuromodulators

Neuromodulators (also called neurotoxins, botulinum toxin injectables, or wrinkle relaxers) are purified forms of botulinum toxin type A (BoNT-A) injected in medical aesthetics to temporarily reduce muscle activity. This smooths dynamic wrinkles — lines caused by repeated facial expressions — for a more youthful, rested appearance. Neuromodulators work by blocking the release of acetylcholine (a neurotransmitter) at the neuromuscular junction. This prevents nerve signals from telling targeted muscles to contract. When the muscle can't fully contract, the overlying skin relaxes, and existing dynamic wrinkles soften or disappear. The effect is reversible and temporary because new nerve endings eventually sprout (neurogenesis), restoring muscle function over time.        Key points:

  • Onset: Typically visible in 3–7 days, with full effect by 10–14 days.

  • Peak effect: Around 2–4 weeks.

  • Duration: Varies by product and individual factors (metabolism, dose, muscle strength, treatment area).

Common FDA-approved neuromodulators (as of 2026):

  • Botox Cosmetic (onabotulinumtoxinA) — the original and most studied; gold standard.

  • Dysport (abobotulinumtoxinA) — diffuses more widely; often preferred for larger areas.

  • Xeomin (incobotulinumtoxinA) — "naked" toxin (no accessory proteins); lower theoretical risk of antibody formation.

  • Jeuveau (prabotulinumtoxinA-xvfs) — newer, aesthetic-focused formulation similar to Botox.

  • Daxxify (daxibotulinumtoxinA-lanm) — peptide-stabilized; longest duration (often 6 months, up to 9+ in some patients); no human serum albumin.

  • Letybo (letibotulinumtoxinA) — recent FDA approval (around 2025); another emerging option with similar mechanism.

All are botulinum toxin type A but differ slightly in formulation, diffusion, onset speed, and longevity. Primarily used for dynamic (expression-related) lines and preventive treatment:

  • Glabellar lines ("11s" or frown lines between brows) — most common FDA indication.

  • Horizontal forehead lines.

  • Crow's feet (lateral canthal lines around eyes).

  • Bunny lines (nose scrunching).

  • Lip lines (smoker's/perioral lines) — small doses.

  • Downturned mouth / marionette lines (depressor anguli oris).

  • Chin dimpling / peau d'orange texture.

  • Neck bands (platysmal bands) — Nefertiti lift.

  • Masseter reduction for jaw slimming / bruxism relief (TMJ/facial slimming).

  • Brow lift or asymmetry correction.

  • Gummy smile reduction.

  • Off-label uses: hyperhidrosis (excessive sweating), migraines (therapeutic), or other muscle-related concerns.

Often combined with dermal fillers in a "liquid facelift" — neuromodulators relax muscles (prevent new wrinkles), while fillers restore volume and smooth static lines.

Procedure Overview

  • Quick in-office treatment (5–15 minutes).

  • Minimal discomfort — very fine needles; ice, topical numbing, or built-in lidocaine sometimes used.

  • No downtime for most; mild redness or small bumps resolve quickly.

  • Results are subtle and natural when dosed conservatively ("baby Botox" trend for prevention in younger patients).

Duration and Maintenance

  • Botox, Dysport, Xeomin, Jeuveau: typically 3–4 months (some last 4–5).

  • Daxxify: often 6 months average, up to 9+ months in responders.

  • Repeat every 3–6 months to maintain results; over time, many need less frequent treatments due to muscle "training."

Risks and Considerations

Generally very safe with experienced injectors.

  • Common: temporary bruising, headache, mild swelling, or asymmetry (resolves in days).

  • Less common: drooping eyelid/brow (ptosis — usually from migration or poor placement), dry eyes, or flu-like symptoms.

  • Rare serious: allergic reaction, unintended muscle weakness, or (extremely rare) distant spread effects.

  • Contraindications: pregnancy/breastfeeding, certain neuromuscular disorders (e.g., ALS, myasthenia gravis), active infection at site.

Neuromodulators are the most popular non-surgical aesthetic treatment worldwide in 2026, offering predictable, natural-looking wrinkle reduction with minimal invasiveness when performed by qualified providers who understand facial anatomy and individualized dosing.